ArticleInternational journal of hematology2018
Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.
Abstract read
In one paragraph
Article in International journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 37 citations in OpenAlex.
- Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.Leukemia · 2026Article
- KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia.Cancer discovery · 2025Article
- Promising activity of Selinexor in the treatment of a patient with refractory NUP98-NSD1+/FLT3-ITD + acute myeloid leukemia.Annals of hematology · 2025Article
- Prognostic importance of NUP98-rearrangements in acute myeloid leukemia: A systematic review and meta-analysis.Caspian journal of internal medicine · 2024Review
- Article
- Article
- Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients.Diagnostics (Basel, Switzerland) · 2022Article
- Development and validation of a prognostic scoring model to risk stratify childhood acute myeloid leukaemia.British journal of haematology · 2022Article
- Poor outcome of pediatric patients with acute myeloid leukemia harboring high FLT3/ITD allelic ratios.Nature communications · 2022Article
- Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia.Blood advances · 2022Article
- First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review.BMC medical genomics · 2021Review
- Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.Experimental hematology & oncology · 2021Article
- Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era.Blood research · 2020Article
- Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.Blood · 2020Review
- Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia.Blood cancer journal · 2020Article
- Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions.International journal of hematology · 2019Article
- Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia.Cancer cell international · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors at 19 institutions in 1 country.
Akira ShimadaDepartment of Pediatric Hematology/Oncology, Okayama University Hospital, Okayama, 2-5-1, Shikatacho, Kita-ku, Okayama, 700-8558, Japan. pajj236e@okayama-u.ac.jp.ORCID http://orcid.org/0000-0001-5207-3779
Yuka Iijima-YamashitaNational Hospital Organization, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
Akio TawaDepartment of Pediatrics, National Hospital Organization, Osaka Medical Center, Osaka, Japan.
Daisuke TomizawaDivision of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Miho YamadaNational Hospital Organization, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
Shiba NorioDepartment of Pediatrics, Yokohama City University, Yokohama, Japan.
Tomoyuki WatanabeDepartment of Nutritional Science, Aichi Gakuin University, Nisshin, Aichi, Japan.
Takashi TagaDepartment of Pediatrics, Shiga Medical University, Otsu, Shiga, Japan.
Shotaro IwamotoDepartment of Pediatrics, Mie University, Tsu, Mie, Japan.
Kiminori TeruiDepartment of Pediatrics, Hirosaki University, Hirosaki, Aomori, Japan.
Hiroshi MoritakeDepartment of Pediatrics, Miyazaki University, Miyazaki, Japan.
Akitoshi KinoshitaDepartment of Pediatrics, School of Medicine, St. Marianna University, Kawasaki, Kanagawa, Japan.
Hiroyuki TakahashiDepartment of Pediatrics, Toho University Omori Medical Center, Tokyo, Japan.
Hideki NakayamaDepartment of Pediatrics, Kyushu Cancer Center, Fukuoka, Japan.
Katsuyoshi KohDepartment of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Hiroaki GotoDepartment of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan.
Yoshiyuki KosakaDepartment of Hematology/Oncology, Kobe Children's Medical Center, Kobe, Japan.
Akiko Moriya SaitoNational Hospital Organization, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
Nobutaka KiyokawaDepartment of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan.
Keizo HoribeNational Hospital Organization, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
Yusuke HaraDepartment of Pediatrics, Gunma University, Maebashi, Japan.
Kentaro OkiDepartment of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan.
Yasuhide HayashiDepartment of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan.
Shiro TanakaDepartment of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Souichi AdachiDepartment of Human Health Science, Kyoto University, Kyoto, Japan.
National Hospital Organization · JPNational Center For Child Health and Development · JPKyoto University · JPAichi Gakuin University · JPGunma Children's Medical Center · JPGunma University · JPHirosaki University · JPKanagawa Children's Medical Center · JPKobe Children's Hospital · JPMie University · JPNational Hospital Organization Kyushu Cancer Center · JPOkayama University Hospital · JPOsaka National Hospital · JPSaitama Children's Medical Center · JPShiga University · JPSt. Marianna University School of Medicine · JPToho University · JPUniversity of Miyazaki · JPYokohama City University · JP
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute myeloid leukemia harboring internal tandem duplication of FMS-like tyrosine kinase 3 (AML
Indexed as
Hematopoietic Stem Cell TransplantationAdolescentAllelesChildChild, PreschoolClinical Studies as TopicFemalefms-Like Tyrosine Kinase 3Genetic HeterogeneityHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHumansInfantIntracellular Signaling Peptides and ProteinsJapanLeukemia, Myeloid, AcuteFLT3 protein, humanfms-Like Tyrosine Kinase 3Histone-Lysine N-MethyltransferaseHistone MethyltransferasesIntracellular Signaling Peptides and ProteinsNPM1 protein, humanNSD1 protein, humanNuclear Pore Complex ProteinsNuclear ProteinsNucleophosminNup98 protein, humanOncogene Proteins, FusionAlleric ratioAMLChildhoodFLT3-ITDNUP98-NSD1
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.